Tudóstér: Makai Attila publikációi

Lieber, A., Makai, A., Orosz, Z., Kardos, T., Susil, J., Tornyi, I., Bittner, N.: The role of immunotherapy in early stage and metastatic NSCLC.
Pathol. Oncol. Res. "Accepted by Publisher"2024.

Sebestyén, E., Major, N., Bodoki, L., Makai, A., Balogh, I., Tóth, G., Orosz, Z., Árkosy, P., Vaskó, A., Hódosi, K., Szekanecz, Z., Szekanecz, É., Hungarian OncoRheumatology Network (HORN) initiative: Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience.
Front Oncol. 13 1-9, 2023.

Makai, A., Kovács, T., Lieber, A., Kardos, T., Orosz, Z., Vaskó, A., Bittner, N., Takács, I.: Nintedanib kezelés 4 év távlatában.
Med. Thorac. 75 (3), 159, 2022.

Opposits, G., Nagy, M., Barta, Z., Aranyi, S., Szabó, D., Makai, A., Varga, I., Galuska, L., Trón, L., Balkay, L., Emri, M.: Automated procedure assessing the accuracy of HRCT-PET registration applied in functional virtual bronchoscopy.
EJNMMI Res. 11 (1), 1-13, 2021.